Home > Drug Search >
  • Targets: Protein phosphatase 2A (PP-2A)
  •   > 
Drug Filter
Status:
Approved (4) Phase Ⅲ (1) Phase Ⅱ (4) Phase Ⅰ (2)
Clinical Stage:
Pending (1) Active (4) Discontinued (2)
Company:
National Cancer Institute (1) Pfizer (2) Sanofi (1) Unknown (2) Velacor Therapeutics (1) Mirati Therapeutics (1) MEI Pharma (1) Aslan (1) Inspyr Therapeutics (1) Lixte (1) Bristol-Myers Squibb (1)
Indication:
Alzheimer's disease (AD) (1) Breast cancer (1) ROS1-positive non-small cell lung cancer(NSCLC) (1) Gastric cancer (1) Glioblastoma multiforme (1) Hepatocellular carcinoma (HCC) (1) Melanoma (1) Non small cell lung cancer (NSCLC) (2) Ovarian cancer (1) Prostate cancer (1) Solid tumours (3) Ulcerative colitis (1) Malaria (2)
Country:
Aprv. Year:
1995 (1) 2011 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top